Recurrent Breast Cancer Completed Phase 1 / 2 Trials for Trastuzumab (DB00072)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02843126Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerTreatment
NCT00258349Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerTreatment
NCT00331552Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerTreatment